Biotechnology Archives

February 17, 2026

Danaher Makes a Splash – What Investors Should Know About the $9.9 Billion Acquisition of Masimo

Danaher is acquiring Masimo in a $9.9 billion all-cash deal. Here’s what the acquisition means for DHR stock, Masimo’s Apple litigation, and long-term investors.

Read this issue

January 22, 2026

This AI power trade is taking off. Are you on board?

Get ready for higher prices. The bull market in solar energy is back on. Over the past four months, I’ve repeatedly made the case for owning solar energy stocks.

Read this issue

December 9, 2025

Why Alzheimer’s Drug Sales Are Set to Surge: Three Key Insights for Biotech Investors

Alzheimer's drug sales are gaining momentum as Leqembi and Kisunla expand globally and new P-Tau blood tests transform diagnosis. Here's what biotech investors need to know.

Read this issue

November 21, 2025

Stock Market Investors: This Is No Time to Panic

The S&P pullback isn’t breaking the bull trend. Inside: why this isn’t a time to panic, homebuilder rebound potential, biotech strength, and an AMZN trade setup.

Read this issue

November 18, 2025

A Boomer Health Care Play Soars to New All-Time Highs: Are You Benefiting From This Megatrend?

Boomer health care stocks, biotech winners, and top oil names are hitting new highs. Here’s what’s driving these megatrends in today’s Money & Megatrends.

Read this issue

November 17, 2025

The Biotech Sector Powers to New Highs, Displaying Phenomenal Strength in a Weak Market

Biotech leads the market with new highs as energy stocks confirm their bull trend and small caps pull back. Today’s Money & Megatrends breaks down the moves.

Read this issue

Biotechnology

Article Date Range

Author

Categories

Danaher Makes a Splash – What Investors Should Know About the $9.9 Billion Acquisition of Masimo

This AI power trade is taking off. Are you on board?

Why Alzheimer’s Drug Sales Are Set to Surge: Three Key Insights for Biotech Investors

Stock Market Investors: This Is No Time to Panic

A Boomer Health Care Play Soars to New All-Time Highs: Are You Benefiting From This Megatrend?

The Biotech Sector Powers to New Highs, Displaying Phenomenal Strength in a Weak Market